Dahms Bradford D. 4
4 · Theseus Pharmaceuticals, Inc. · Filed Dec 22, 2021
Insider Transaction Report
Form 4
Dahms Bradford D.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-12-21$10.15/sh+1,970.036$20,000→ 1,970.036 total
Footnotes (1)
- [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $10.09 to $10.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.